Interactive Brokers Advertisement
Home > Boards > US OTC > Medical - Equipment >

Arrayit Corporation (ARYC)

Add ARYC Price Alert      Hide Sticky   Hide Intro
Moderator: lucky,mydog, techmover, bz777, gentle09, whento, HighYieldStocks
Search This Board: 
Last Post: 10/21/2017 8:24:00 PM - Followers: 443 - Board type: Free - Posts Today: 2



ARYC is a Silicon Valley company that is currently trading under a penny per share but not for much longer. Sales of its microarray products are in excess of $30,000 to $40,000 per day!! Please research this Silicon Valley company. This company has potential of trading in excess of $5 per share:


Follow  @Arrayit and $ARYC on Twitter


Arrayit Corporation on Facebook 


No share increase per CEO.....!!!!!..  AND......Trading at .6x earnings....... Yes, point 6 times!

Estimated earnings of $8 million last year and it is also located in the heart of Silicon Valley near Apple, Yahoo, AMD, Juniper, MBZ, LinkedIn, Facebook and many, many other leaders of the tech industry. 


Trading at an incredibly low share price under a penny.


2 contracts signed last year for a total of approximately $51 million over the next 3 years ......


No other sub penny company has the potential of ARYC  


Please check out their tweets @Arrayit or go to their Facebook page: Arrayit Corporation 




Please check their products that are selling in the tens of thousands of dollars daily. 


Link to their products:


Arrayit's new corporate headquarters, located at 927 Thompson Place, Sunnyvale, California, 94085, feature 15,000 square feet of modern industrial space including 45 parking spaces, offices, conference rooms, demonstration laboratories, class 100 cleanrooms, and manufacturing and shipping facilities.


ARYC is continuing  a strong and steady move up on steady  volume.  Please take some time to review the ARYC board with due diligence done by investors.



Arrayit reports $46,000 microarray services sale to a leading proteomics research company located in the central USA 

(link: ;… 


Arrayit signs 3-year $24.4 million patented microarray technology sales and marketing agreement with a leading laboratory services provider.


ARYC: Arrayit Corporation 


@Arrayit on Twitter 


Link to their products:


ARYC also owns 40 million shares of AVDX. A value of $12 million +


Arrayit wins technical specification bid on $110,000 microarray instrument government tender with top life sciences distributor in India.


$ARYC.....Arrayit on-line company Store sales exceed $54.5 million all-time on 226,285 microarray products and services sold



Corporate Overview

Arrayit Corporation is a leading life sciences company providing innovative products and services to empower scientists and clinicians to explore the human genome as well as the genomes of plants and animals. Arrayit's worldwide business position leverages the company's widely used patented microarray manufacturing platform and revolutionary VIP™ genotyping technology. Nearly every major research center in the world uses Arrayit products including research laboratories, pharmaceutical companies, universities, biotechnology companies, hospitals, government agencies, and nonprofit research organizations. Novel insights into the function of genes and proteins, early stage disease diagnostics, better and safer medicines, and more nutritional crop plants are some of the many aspects of human health empowered by Arrayit technology.

Corporate Philosophy
Arrayit is an exciting and innovative public company that strives to increase shareholder equity by inventing, developing, manufacturing and supplying sophisticated life sciences products and services to an extensive customer base spanning 50 countries.
Our corporate philosophy is embodied by a highly skilled, multidisciplinary team of investors, business professionals, scientists, engineers and executive and support staff who place shareholder value, product quality, customer service and price competitiveness as our highest priorities. Arrayit empowers decisive strategic advantage and large return on investment for our customers in the research, pharmaceutical, diagnostic, and health care markets.

Corporate History
Arrayit Corporation was founded in 1993 by Rene' Schena and Todd Martinsky as TeleChem International, Inc, a chemical import and export company specializing in plastics, water soluble fertilizers, alternative fuels, and the life sciences. After several years of successful revenues growth, the company expanded in 1999 by adding Dr. Mark Schena and Paul Haje, who together with Ms. Schena and Mr. Martinsky, founded Arrayit Life Sciences, a division of TeleChem International, Inc. Arrayit sought to build on the opportunities created by the deciphering of the human genome and the rise of microarray technology. Arrayit microarrays are sophisticated glass substrates containing large collections of DNA and protein spots that allow all 25,000 human genes and every major protein in the human body to be analyzed in a few hours. Arrayit VIP™ microarrays enable the analysis of the DNA from 100,000 patients in one day. Since 1999, Arrayit has has build a powerful portfolio of patents, trade secrets, and more than 650 life sciences products. The company was featured on the television series
NOVA in 2001, received successive appointments to the Inc. 500 list in 2002 and 2003, and has received numerous local awards including the Rising Star award from the City of Sunnyvale and the
Silicon Valley 50 award in 2003. The company changed its name to Arrayit Corporation and began trading on the OTC Bulletin Board in 2009 as ticker symbol ARYC. The company's products and services are used in the life sciences, pharmaceutical, and diagnostics markets, which are estimated at $690 billion in annual revenue.


OvaDx® Ovarian Cancer Diagnostic Test

In Development

Arrayit Diagnostics, Inc. provides the market's first large panel biomarker screening test for ovarian cancer. OvaDx® is a sophisticated microarray-based test that measures the activation of the immune system in blood samples in response to early stage ovarian tumor cell development. Research studies with OvaDx® indicate high sensitivity and specificity for all types and stages of ovarian cancer including stage IA-IV borderline serous, clear cell, endometrioid, mixed epithelial, mucinous, serous, and ovarian adenocarcinoma. Upon FDA approval, Arrayit Diagnostics will offer OvaDx® as an elective test for women seeking greater wellness and for women in the elevated risk category for ovarian cancer. OvaDx® will be used by doctors to advance the forefront of ovarian cancer treatment including improved surgical options, more effective chemotherapies, and to supplement existing tests including CA-125, OVA1®, and transvaginal ultrasound.


Diagnostics - Parkinson's Disease

Parkinsons Disease
Arrayit has leveraged the company's patented and proprietary microarray discovery platform to decipher the molecular basis of Parkinson's Disease (PD). This important research project, completed as a collaboration with The Parkinson's Institute (Sunnyvale, California), offers exciting promise for the pre-symptomatic and post-symptomatic diagnosis and treatment of this serious neurodegenerative condition. Arrayit is currently seeking a strategic partner to accelerate FDA approval of the Arrayit PDx™ Parkinson's Disagnostic Test, speed the benchmarking of PDx™ as a companion diagnostic, and determine and enhance the efficacy of pipeline therapeutic proteins and small molecules.


Avant Diagnostics, Inc.

Definitive diagnostic screening test for early stage detection



About Avant Diagnostics, Inc.


Avant Diagnostics, Inc., ("AD") previously named Arrayit Diagnostics, Inc., is a Nevada corporation presently a majority-owned subsidiary of Arrayit Corporation ("Arrayit"). AD's business is based upon the completion of the human genome sequencing project. Genetic research is increasingly focused on identifying the variations of the specific genes in the genome. These variations are what define individual characteristics, including disease states or a statistical propensity for disease. The implications are far-reaching and impact not only the research community, but also the individual patients and the medical providers. Diagnostic tests that detect diseases very early in their progression will provide options for earlier treatments that may improve the patient's quality of life and prognosis by delaying or preventing disease progression or even death. Medical providers will incur major cost savings by avoiding costly late stage disease treatments.


© 2013 by Avant Diagnostics, Inc., all rights reserved.

Related Articles

Interactive Brokers Advertisement
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
#57984  Sticky Note We are awaiting completion of the audit covering gentle09 10/02/17 02:24:41 PM
#57289  Sticky Note ARYC (Arrayit Corporation) is a Silicon Valley biotech whento 09/25/17 12:32:11 PM
#57269  Sticky Note For those who are new to Arrayit Corporation, HighYieldStocks 09/25/17 12:10:10 PM
#56520  Sticky Note NEW INVESTORS READ: bz777 09/21/17 11:06:03 AM
#56358  Sticky Note For those who are new to the board: techmover 09/20/17 01:49:45 PM
#56228  Sticky Note TO REPORT ARYC TO THE SEC..... lucky,mydog 09/20/17 10:56:53 AM
#58923   Anticipation is building again;) should be a good week TravO 10/21/17 08:24:00 PM
#58922   Great week and looking forward to next. Everyone Jeffpacman 10/21/17 11:36:05 AM
#58921   Next year we go to Dollar land. GVInvestments 10/20/17 06:04:53 PM
#58920   If you know what you own, it is TravO 10/20/17 05:17:44 PM
#58918   I think people said that months ago before TravO 10/20/17 05:10:40 PM
#58917   It will be last VERT Anty_Jr 10/20/17 04:36:36 PM
#58916   We will see my friend......$$$$$$$$ millions213 10/20/17 04:27:18 PM
#58915   tick is definitely not going to increase The_Free_Nebula 10/20/17 04:19:24 PM
#58913   This is looking darned well... HighYieldStocks 10/20/17 04:13:25 PM
#58912   You will see a lot of GREEN soon. millions213 10/20/17 04:11:45 PM
#58911   wow actually some green The_Free_Nebula 10/20/17 04:02:06 PM
#58909   Pps looking good and heading back up! millions213 10/20/17 03:28:04 PM
#58907   Pps looking good and heading back up! techmover 10/20/17 02:57:11 PM
#58906   NEW tweet...Arrayit ships microarray consumables sale to advanced HighYieldStocks 10/20/17 02:05:57 PM
#58905   You only become a friggin bagholder if the techmover 10/20/17 01:28:22 PM
#58904   not excited at all...I very much doubt they The_Free_Nebula 10/20/17 01:26:35 PM
#58903   No. Much more likely it will be around rh22 10/20/17 01:20:55 PM
#58901   Latest speculation - that Filings will come this The_Free_Nebula 10/20/17 01:16:24 PM
#58900   Fake tweets will not fuel any rocket here..only Starlight84 10/20/17 01:15:44 PM
#58899   Not really, if you smart you make money Dupie 10/20/17 01:11:30 PM
#58898   Red will be back..just a short break Starlight84 10/20/17 12:53:37 PM
#58896   Finally some green The_Free_Nebula 10/20/17 12:47:06 PM
#58894   This is good at 0.001 I will wait patiently Starlight84 10/20/17 12:42:15 PM
#58893   Lol, me to. I think this is my Jeffpacman 10/20/17 12:40:28 PM
#58892   You not getting mine. I already won the millions213 10/20/17 12:29:36 PM
#58891   They don reply emails..don pick up calls..n where Starlight84 10/20/17 12:05:43 PM
#58890   I'll keep to the tweets, better odds, but thanks Jeffpacman 10/20/17 11:52:22 AM
#58889   I will have better odds with this one, techmover 10/20/17 11:51:12 AM
#58886   U will have better odds buying a lottery Starlight84 10/20/17 11:48:27 AM
#58885   NEW tweet...Arrayit sales team receives sponsorship invitation to HighYieldStocks 10/20/17 11:46:54 AM
#58884   Two years of tweets with company names and Jeffpacman 10/20/17 11:42:52 AM
#58883   NEW tweet...Arrayit reports microarray technology sale to agricultural HighYieldStocks 10/20/17 11:38:58 AM
#58882   For those who say done any research and Starlight84 10/20/17 11:35:08 AM
#58881   NEW tweet...Arrayit reports microarray technology sale to single HighYieldStocks 10/20/17 11:31:19 AM
#58880   NEW tweet...Arrayit reports microarray technology sale to controlled HighYieldStocks 10/20/17 11:31:01 AM
#58879   NEW tweet...Arrayit reports $16,500 microarray services sale to HighYieldStocks 10/20/17 11:30:50 AM
#58876   The MM have been buying small lots at Pokerjoe 10/20/17 10:50:06 AM
#58875   Yep. techmover 10/20/17 10:47:36 AM
#58874   That's why you can't let emotions dictate your SK510 10/20/17 10:46:52 AM
#58870   Is the market telling us bag holders that rh22 10/20/17 10:07:30 AM
#58868   Another great day for ARYC... Keep it going... Jeffpacman 10/19/17 10:09:58 PM
#58867   Anyone done any dd on tis? Like went Starlight84 10/19/17 10:03:36 PM
#58866   Is UVS on vacation? I just returned from jdemuss 10/19/17 09:42:38 PM
#58865   I picked up a bunch of cheap shares 0cash 10/19/17 08:30:09 PM
#58863   In the meantime folks need to catch the The_Free_Nebula 10/19/17 05:07:42 PM
#58861   Aryc filing will be released soon. Patience will Ken1998 10/19/17 05:02:16 PM
#58860   Kudos to the brave souls that made those The_Free_Nebula 10/19/17 03:38:12 PM
#58858   Agreed GBG! Perfect timing! Toofast 10/19/17 02:23:26 PM
#58857   Arrayit Trying to con people who read the MikeCr 10/19/17 02:00:57 PM
#58855   OLD...... aryc is an sec filing scam. lucky,mydog 10/19/17 01:35:38 PM